To test this hypothesis, immunohistochemical staining for two potential miR-182 targets, FOXO1 and FOXO3a, were performed on 10 of the 15 matching tissue sets from SBU CA and AA colon cancer patients (Fig. 3). Here, FOXO3 is linked to colonic neoplasm.